The CDC's independent panel has voted unanimously to recommend both Moderna and Johnson & Johnson vaccine boosters for certain populations.

       The panel recommended a third dose for Moderna vaccine recipients at least six months after a person’s initial course for those 65 and older, and those as young as 18 who are at higher risk due to their underlying health conditions, or where they work or live.

       Angela Weiss/AFP via Getty Images, FILE

       A medical staff member prepares a syringe with a vial of the Moderna COVID-19 vaccine at a pop up vaccine clinic at the Jewish Community Center in the Staten Island, N.Y., April 16, 2021.

       This aligns with what was recommended for a third booster dose for recipients of the Pfizer vaccine.

       A second dose for those that received a one-shot Johnson & Johnson vaccine was recommended for anyone 18 years and older, at least two months after their first dose.

       MORE: FDA authorizes boosters for Moderna and J&J vaccines

       The panel also cleared the way for allowing mixing and matching of booster doses, meaning they will allow for people to get a different brand as a booster than was used for a primary vaccination.

       Universal Images via Getty Images

       A nurse shows a vial of the Moderna Covid-19 vaccine.

       Echoing the FDA however, CDC advisors today did not say any booster combination was preferred over another.

       MORE: As White House announces vaccine plan for kids ages 5-11, states prepare for complex rollout

       CDC’s advisory vote follows -- and falls in line with -- FDA’s move Wednesday to authorize those boosters, and aligns with what FDA and CDC authorized for the Pfizer vaccine booster shots last month.

       CDC Director Rochelle Walensky must now give the final signoff to the panel's recommendation, which is typically expected within a day.